[Clinical study of a new cephalosporin ceftriaxone (Ro 13-9904) in sepsis and other infectious forms of particular severity].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001442:Bacteroides Infections / Q000188:drug therapy*; D002439:Cefotaxime / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002443:Ceftriaxone; D002986:Clinical Trials as Topic; D004927:Escherichia coli Infections / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged; D011512:Proteus Infections / Q000188:drug therapy*; D011513:Proteus mirabilis; D018805:Sepsis / Q000188:drug therapy*; D013290:Streptococcal Infections / Q000188:drug therapy*
D002443:Ceftriaxone; D002439:Cefotaxime
Studio clinico di una nuova cefalosporina il Ceftriaxone (Ro 13-9904) nelle sepsi e in altre forme infettive di particolare gravità.